4//SEC Filing
Rice Steven J. 4
Accession 0001209191-21-067656
CIK 0001706431other
Filed
Dec 1, 7:00 PM ET
Accepted
Dec 2, 5:12 PM ET
Size
9.0 KB
Accession
0001209191-21-067656
Insider Transaction Report
Form 4
Rice Steven J.
Chief Administrative Officer
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-11-30−10,000→ 424,441 totalExercise: $12.76Exp: 2029-12-10→ Common Stock (10,000 underlying) - Sale
Common Stock
2021-11-30$50.00/sh−10,000$500,000→ 20,600 total - Exercise/Conversion
Common Stock
2021-11-30$12.76/sh+10,000$127,600→ 30,600 total
Footnotes (3)
- [F1]Includes 600 shares of common stock acquired by the reporting person on November 30, 2021 pursuant to an employee stock purchase program.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2021.
- [F3]1/4 of the shares subject to the stock option vest and become exercisable on September 15, 2020, and the remainder vest in 36 equal monthly installments thereafter.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001820108
Filing Metadata
- Form type
- 4
- Filed
- Dec 1, 7:00 PM ET
- Accepted
- Dec 2, 5:12 PM ET
- Size
- 9.0 KB